Equilibrium unfolding studies of sheep liver tetrameric serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) revealed that the enzyme assumed apparent random coil structure above 3 M guanidine hydrochloride (GdnHCI). In the presence of non-ionic detergent Brij-35 and polyethylene glycol, the 6 M GdnHCI unfolded enzyme could be completely (> 95%) refolded by a 40-fold dilution. The refolded enzyme was fully active and had kinetic constants similar to the native enzyme. The midpoint of inactivation (0.12M GdnHCI) was well below the midpoint of unfolding (1.6 + 0-1 M GdnHC1) as monitored by far UV CD at 222 nm. In the presence of PLP, the midpoint of inactivation shifted to a higher concentration of GdnHCI (0.6 M) showing that PLP stabilizes the quaternary structure of the enzyme. However, 50% release of pyridoxal-5'-phosphate (PLP) from the active site occurred at a concentration (0.6M) higher than the midpoint of inactivation suggesting that GdnHCI may also act as a competitive inhibitor of the enzyme at low concentrations which was confirmed by activity measurements. PLP was not required for the initiation of refolding and inactive tetramers were the end products of refolding which could be converted to active tetramers upon the addition of PLP. Size exclusion chromatography of the apoenzyme showed that the tetramer unfolds via the intermediate formation of dimers. Low concentrations (0-3--0-6M) of GdnHC! stabilized at least one intermediate which was in slow equilibrium with the dimer. The binding of ANS was maximum at 0.4--0-6 M GdnHCI suggesting that the unfolding intermediate that accumulates at this concentration is less compact than the native enzyme.
Introduction
Serine hydroxymethyltransferase (SHMT, EC 2.1.2.1), a pyridoxal-5'-phosphate (PLP) dependent enzyme, catalyzes the reversible interconversion of serine and glycine, a reaction which is the major source of one-carbon substituted folate cofactors that are essential for the synthesis of thymidylate, methionine and various other biomolecules. The urea-induced reversible unfolding of Escherichia coli SHMT (eSHMT) , which is a dimer has been studied in detail, eSHMT, denatured with 8.3 M urea, could be refolded completely by a 10-fold dilution into 20mM "Iris buffer, pH 7.5, containing 5 mM of 2-mercaptoethanol (2-ME) and 1 mM ethylenediaminetetraacetic acid (EDTA). The enzyme initially refolds into an apodimer at 4~ which binds PLP only when the temperature is raised to 30~ (Cai et al 1995) .
Further, the equilibrium unfolding and refolding studies with tryptophan mutants and protease sensitivity during refolding, revealed that the unfolded enzyme has two domains that rapidly fold to form monomers in which the N terminal 55 amino acids and a segment between residues 225-276 are disordered. This partially folded enzyme can form dimers and slowly undergo conformationai change to the native state (Cai and Schirch 1996a ). Fluorescence energy transfer and fluorescence anisotropy measurements on these tryptophan mutants of eSHMT show that the active site lysine 229 bound PLP Keywords. GdnHCI denaturation; reversible untblding; otigomeric proteins; PLP-dependent enzymes; serine hydroxymethyltransferase J. Biosci., 24, No. I, March 1999, pp 69-77. 9 Indian Academy of Sciences 69 remains more than 50/~ away from any tryptophan residue until the final rate-determining conformationai change when it approaches each Trp residue at the same rate (Cai and Schirch 1996b) .
SHMT isolated from sheep liver, on the other hand, is an oligomeric protein of four identical subunits (subunit M r 53 kDa), The enzyme requires PLP for its catalytic activity. PLP present at the active site linked to lysine 256 of the enzyme via a Schiff's base gives a convenient visible spectral handle to monitor the changes at the active site. Also, the cofactor can be removed from the active site to get apoenzyme or alternatively the Schiff's base can be reduced with NaBH 4 to a non-hydrolyzable phosphopyridoxyl lysine adduct at the active site. These two forms of the enzyme can be used to determine the role of the cofactor in the protein folding process.
The sheep liver SHMT has 25% a-helical content as determined by UV CD spectroscopy (Manohar et al 1982; Bhaskar et al 1994; Brahatheeswaran et al 1996) . Recently, the 3-dimensional structure of human liver tetrameric SHMT, which shares 90% identity with sheep liver SHMT, was determined (Renwick et al 1998) . The monomer consists of three domains. The N-terminal small domain (residues 11-53) folds into 2a helices and one fl strand. The middle large domain (residues 53-321) binds PLP and contains 9 helices and 7 stranded mixed fl sheet. The C-terminal domain also contains an antiparallel fl sheet and 4 helices. The quaternary structure is a 'dimer of dimers' as suggested by us earlier (Jagath et al 1997a, b, c) . PLP is at the interface of tight dimers and explains our earlier observations on its role in maintaining the oligomeric structure of the enzyme (Brahatheeswaran et al 1996; Jagath et al 1997a, b, c; Talwar et al 1997) .
In an earlier study, it was established that the ureainduced unfolding of tetrameric SHMT was reversible only in the presence of a non-ionic detergent, Brij-35, and polyethylene glycol (PEG-3350). The refolding was dependent on the protein concentration and temperature. Maximum refolding was achieved only when the final protein concentration was less than 25 lxg/ml and the refolding temperature was 30~ The tetramer was found to unfold via a 'pre-denaturation transition' characterized by the dissociation of the tetramer into dimers followed by the formation of a putative unfolding intermediate as monitored by the far UV CD and 8-anilinonaphthalene sulfonic acid (ANS) binding properties of the protein at intermediate concentrations of urea (1-2 M). The cofactor, apart from its role in catalysis, served to stabilize the quaternary structure of the enzyme and also afforded considerable protection against urea-induced unfolding, in the case of reduced holoSHMT (Venkatesha et al 1998) .
In the present paper, we describe the reversible dissociation and unfolding pathway of sheep liver SHMT in the presence of GdnHCI and show the presence of at least one detectable unfolding intermediate which is stabilized at low concentration of GdnHCI.
Materials and methods
The following chemicals were obtained from Sigma Chemicals Co., St. Louis, MO, USA: 2-ME, EDTA, DL-dithiothreitol (DTI'), PLP, guanidine hydrochloride (GdnHCI), D-alanine, polyethylene glycol-3350 (PEG-3350), polyoxyethyelene-23-1auryl ether (Brij-35, 30% w/v); L-[3-14C]serine (55 mCi/mmol) was from Amersham International, Bucks, England; 5, 6, 7, was prepared by the method of Hatefi et al (1959) . All other chemicals used in the study were of the highest purity available.
Large scale purification of SHMT from sheep liver was achieved by the procedure described by Baskaran et al (1989) . The enzyme was dialyzed against 50 mM potassium phosphate buffer, pH 7.3, containing 1 mM 2-ME, 1 mM EDTA with four changes to remove excess PLP and such an enzyme free of excess PLP was used in all the experiments. The apoenzyme was prepared from the holoenzyme using D-alanine as the substrate (Schirch et al 1993) . Protein concentration was determined by the method of Lowry et al (1951) using bovine serum albumin as the standard. Enzyme activity was determined as described by Manohar et al (1982) using L-[3-~4C]serine as substrate. Activity of the apoenzyme was determined after a short pre-incubation (3 min) with 50 ~M PLP. The reduced holoenzyme was prepared by reducing the Schiff's base linkage with sodium borohydride (200 ~tmol) for 1 h at 4~ in the dark (Schirch et al 1993) .
Equilibrium unfolding studies
The buffer used in the following studies consisted of 50 mM potassium phosphate buffer, pH 7.3, 1 mM DTI', 2 mg/ml PEG-3350, 0-02% Brij-35 (buffer A), +50 I.tM PLP and the specified concentration of GdnHCI.
a Guanidine hydrochloride-induced inactivation:
The holoenzyme (25 I, tg/ml) was incubated with various concentrations of GdnHCI at either room temperature (30 + 2~ or at 4~ for 4 h. At the end of incubation, an aliquot of the mixture was assayed. Corresponding concentrations of GdnHC! were included in the assay buffer also to prevent refolding during the assay. In the experiment where the apoenzyme was treated with GdnHCI, 50 IxM PLP was added 3 min before the assay and enzyme activity determined.
2.1b Circular dichroism measurements:
Far UV circular dichroism measurements were made at 25~ with a Jasco J720 spectropolarimeter using a bandwidth of 1 nm and scan speed of 20 nm/min. The protein concentration was 25 ~tg/ml. Each sample was scanned 10 times and an average ellipticity at 222 nm after correcting for the buffer reading was used to calculate the mean residue ellipticity (0MR E) using the equation
where 0 = observed ellipticity, MRW = mean residue molecular weight (ll0.4Daltons), c=concentration of protein in mg/mi, d= path length in cm.
2.2a Size-exclusion chromatography of the refolding intermediates:
A Superose 6 HR 10/30 analytical size-exclusion chromatography column was used on a Pharmacia FPLC instrument to separate the refolding intermediates. The column was equilibrated with buffer A containing 0.15 M GdnHCI and 0.1 M KCI. The column was calibrated with standard proteins of known M r . Aliquots (2.5 [.tg/0.2 ml) were injected at various time intervals. The absorbance of the eluate was monitored at 280 nm.
Results

2.1c
Fluorescence spectroscopy: (i) Intrinsic fluorescence: Intrinsic fluorescence measurements were made at 25~ using a Spex fluorolog spectrofluorimeter. Protein concentration was 25 [tg/ml. The excitation wavelength was 280 nm and the bandwidth was 3.55 nm. Fluorescence intensities at 329 nm for the holo-, reduced holo-and the apoenzyme, where the difference between native and 6 M GdnHC! unfolded protein was maximum, were converted to relative fluorescence and plotted against GdnHC1 concentration.
(ii) Data analysis: The fluorescence and CD data were converted to plots off, pp versus denaturant concentration according to Nath and Udgaonkar (1995) .
(iii) ANS fluorescence: The proteins (501xg/ml) were incubated with various concentrations of GdnHCI for 4 h at 25~ An aliquot of the stock ANS was added at the end of incubation such that the final concentration of ANS was 201.tM. The fluorescence was monitored at 489 nm after exciting at 373 nm using a bandwidth of 3-55 nm. Each data point is an average of ten such scans after subtracting for the buffer reading. The ANS fluorescence at 0 M GdnHCI was taken as 100%.
2.1d Size exclusion chromatography:
A Superose 6 HR 10/30 analytical gel filtration column was used on a Pharmacia FPLC system for monitoring the changes in the protein elution pattern as a function of GdnHCI concentration. The protein concentration was 62.5 lag/ml and was incubated in buffer A containing 0.1 M KCI and the desired concentration of GdnHCl. The column was calibrated with standard markers of known M r.
Refolding of SHMT ut!folded in 6 M GdnHCI
Refolding of SHMT from 6 M GdnHCI was initiated by a 40-fold dilution of unfolded protein into the refolding buffer (buffer A) in the presence and absence of 50 ~tM PLP such that the final protein and GdnHCI concentrations were 12.5 ~tg/ml and 0.15 M, respectively. Native protein incubated with 0.15 M GdnHCI under identical conditions served as the control. The apoenzyme was also refolded in a similar way by dilution of GdnHCI. The refolded enzymes were assayed either immediately or after l h incubation at 30~ 3.1 GdnHCl-induced unfolding of SHMT 3.1a Activity studies: The enzymes, either holo or apoenzyme (25 I.tg/ml) were incubated with various concentrations of GdnHCI at room temperature and residual activity was assayed at the corresponding GdnHCI concentration, after 2 h. A plot of residual activity against GdnHCI is given in figure 1. It can be seen that the activity progressively decreased with increasing concentration of GdnHC1 and almost complete activity was lost in the case of apo-and holoSHMT at 0.5 M GdnHC1. The midpoints of inactivation for the apo-and holoSHMT were 0.25 and 0.12M GdnHCI, respectively. It should be mentioned that the apoenzyme was reconstituted with 50 [.tM PLP before the assay, whereas the holoenzyme was assayed in the absence of any added PLP. When the inactivation was carried out in the presence of excess PLP (50 laM) the denaturation curve shifted to the right and complete inactivation was observed at 0-9 M GdnHCI. The shift in the concentration required for 50% inactivation (0.6 M) upon the addition of PLP suggested that PLP stabilizes the native enzyme to some extent. In order to monitor the loss of PLP from the active site, the holoenzyme (125 lag/ml; in the absence of any added PLP) was incubated at concentrations of GdnHC! indicated in figure 1 and dialyzed against buffer containing the corresponding concentration of GdnHCI. The absorbance at 425nm was monitored and as shown in figure 1 (open triangles) the loss of PLP from the active site occurred at higher concentrations of GdnHC! (0.6M, midpoint) compared to the midpoint of inactivation (0.12M). This and the earlier observation from this laboratory, which had suggested that aminoguanidine compounds function as inhibitors of SHMT activity (Acharya and Appaji Rao 1992) , indicated that the extreme sensitivity of SHMT to inhibition by GdnHCI at low concentration could be due to inhibition by interaction at the active site. In order to examine this further, the holoenzyme (25 ~tg/ml) was incubated at 0, 0.075 and 0.15M GdnHCI for 2h. The activity of this enzyme was assayed at varying concentrations of L-serine in the range 0--4 mM. The enzyme, in the absence of GdnHCI, served as the control. It can be seen from the double reciprocal plot (figure 1, inset) that the lines intersect at a common point on the Y-axis indicating that GdnHC! may be functioning as a competitive inhibitor of the enzyme at low concentrations. The K i value calculated from this data was 40 mM.
3.1b Spectral studies: GdnHCI-induced unfolding of holo-, apo-and reduced holoenzyme was monitored by using far UV CD and fluorescence spectroscopy. Figure 2a represents the secondary structural changes of all the three forms of the enzyme upon incubation with GdnHCI. Though reduced holoSHMT was marginally more stable compared to the holo-and apoSHMT at low denaturant concentration, unfolding midpoints of all the 3 forms of the enzyme are similar (t.6+0-1 M GdnHCI). Above 3 M GdnHCI all the proteins assume apparent random coil structures. Fluorescence intensity, which indicates the environment around the tryptophan side chains, remains unchanged up to 0-8 M GdnHCI in all the 3 forms of the enzyme. Above 3 M the tryptophan side chains become completely exposed to the solvent. The unfolding midpoints as monitored by fluorescence for the holo/apoenzyme and reduced holoenzymes are 2.0 and 2-2M GdnHCI respectively (figure 2b). The observation that the midpoints of denaturation of reduced holoSHMT and other two forms of SHMT are similar, indicates that the PLP present at the active site as a stable phosphopyridoxyl lysine residue does not afford any significant protection against GdnHCl-induced unfolding unlike in the case of urea-induced unfolding (Venkatesha et al 1998) . The noncoincidence of denaturation curves also suggests that the unfolding of SHMT may not be occurring by a two state mechanism.
Size exclusion chromatography
The changes in the hydrodynamic volume of apo-, holoand reduced holoenzymes as a function of GdnHCI were monitored using size exclusion chromatography ( figure  3a, b, c) . In the absence of any denaturant, holo and reduced holoenzymes eluted as a single symmetrical peak (peak 1) whose elution volume corresponded to 210 kDa when compared to the elution profiles of the standard M, markers processed under identical conditions. It is evident from figure 3a that the apoenzyme dissociated at lower concentrations of GdnHCI (0.15-0.3 M) as indicated by the appearance of a protein peak (peak 2) whose hydrodynamic volume was less than that of the tetrameric form. The apparent M r of the dissociated Figure 3 . Size exclusion chromatography of the GdnHCI treated SHMTs. Proteins (125 ILtg/ml) incubated at the specified concentrations of GdnHCI were chromatographed on a FPLC Superose 6 HR t0/30 column equilibrated with the same concentration of GdnHCI in buffer C. The flow rate was 0-4 mi/min. (a, b and c), Elution profiles obtained with apo-, hoto-and reduced holoSHMT, respectively. The column was calibrated with cytochrome C (12,900) carbonic anhydrase (29,000), BSA (66,000), alcohol dehydrogenase (150,000), flamylase (200,000) and apoferritin (443,000).
tetramer was determined using standard M r markers developed at 0.15M GdnHCI and was found to be 120 kDa which approximately corresponded to the dimeric form of SHMT. With increasing denaturant concentration, the dimet began to unfold and eluted earlier upon gel filtration. Interestingly at 0.45 M GdnHCI, two peaks with elution volume 16-2 ml (peak 2) and 15.2 ml (peak 3) were observed. The peak 2 corresponded to the dimeric form and peak 3, although eluting at the same position as the native tetramer, does not represent the folded 300 tetrarner as the native tetramer was almost completely dissociated by 0.2 M GdnHCI. Therefore, it might represent an unfolding intermediate which is less compact 200 than the dimer and more compact than the completely / unfolded form. The equilibrium between the dissociated tetramer and this intermediate is slow when compared 100 to the time of chromatography, hence they can be separated on the column. The hoio (figure 3b) and reduced 0 holo enzymes (figure 3c), on the other hand, do not show the presence of dimer at low concentrations of 3OO GdnHCi. This is probably because dissociation and ---unfolding are simultaneous in this case. Beyond 0.6 M GdnHCI, the elution profiles of both holo-and reduced hoIoSHMT shift to the left indicating an increase in ~ 200 Stoke's radius as the proteins begin to unfold..The us presence of only a single peak beyond 0.6 M GdnHCI ~ concentration indicated that the equilibrium between corn-t~ 100 tn pletely folded and other forms (unfolded or unfolding m intermediate, if any) was very fast when compared to o the time for chromatography. Hence, these peaks representu. 0 the weighted average of all the forms present at equi-0 librium. Above 3 M GdnHCI, there was no significant change in the elution volume up to 6 M indicating that 300 the proteins unfold almost completely by 3 M GdnHCI.
ANS binding studies 200
The binding of the hydrophobic fluorescent dye, ANS, can be used as a very sensitive tool to monitor the exposure of hydrophobic regions of a protein. Both holoand apoSHMTs show increased ANS binding even at very low concentrations of GdnHCI. The ANS binding continues to increase up to 0.6M GdnHCI and then decreases before reaching a minimum at 2 M GdnHCI (figure 4), A comparison of ANS binding curves obtained using the holo-and apo-forms of the enzyme indicates that they are essentially similar. This suggests that the holoenzyme may also follow a similar unfolding pathway as that of the apoenzyme, although the holoenzyme does not show any apparent dissociation and the formation of an unfolding intermediate. and reduced holoSHMT (c) (50 ktg/ml) were incubated with various concentrations of GdnHCI. ANS (101aM) was added and the fluorescence intensity at 489 nm was monitored after exciting at 372 nm.
Reversibility of unfolding
SHMT incubated in the presence of 6 M GdnHCI had an apparent random coil structure with its tryptophan side chains completely exposed to solvents as monitored by far UV CD and fluorescence, respectively. Such an enzyme could be refolded to recover > 95% activity, by 40-fold dilution into refolding buffer. The recovery of enzyme activity was maximum when the final protein concentration was 12.5 I.tg/ml and the refolding temperature was 30~ The kinetic and spectral properties of the control and refolded SHMTs were comparable (table 1) . The absence or presence of PLP during the initial stages of refolding did not affect the final recovery of activity. PLP added just before the assay was able to restore activity, suggesting that the coenzyme may not be required for the initiation of refolding. Oligomeric status of the protein during refolding was monitored by size" exclusion chromatography as described in w 2. The profiles are represented in figure 5 . The protein Fluorescence (relative to 1 for the native SHMT) 1 > 0.95 when refolded either in absence or presence of PLP eluted as a single peak with a retention volume of 15.2 ml which corresponds to the elution volume of the native tetramer under similar conditions. But the enzyme refolded in the absence of the coenzyme is inactive and can be converted to the active form by the addition of PLP.
Discussion
It is becoming increasingly evident that intermediary structures precede the final folded conformation (Matthews 1993; Ptitsyn et al 1995) . Hence it is of utmost importance to stabilize these intermediates under equilibrium conditions. Folding intermediates become populated when the native structure is sufficiently destabilized by perturbing a strong tertiary interaction between two units of secondary structure, incubating the apoproteins under mildly denaturing conditions (Kirby and Steiner 1970; Kuwajima 1989) or by varying the nature of the denaturant. In an earlier study, urea was used to denature sheep liver SHMT. In the present study we have characterized the pathway of GdnHCI-induced reversible unfolding of sheep liver SHMT which shows that the change in the denaturant does affect the equilibrium distribution of intermediates. If a protein requires a coenzyme/cofactor for its stability and activity, the removal of the coenzyme/cofactor renders the apoproteins less stable than the corresponding holoproteins. This results in the accumulation of unfolding intermediates under mildly denaturing conditions. The results presented here on the GdnHCI-induced unfolding of the holo-and apoSHMTs show that some of the intermediates are indeed stabilized upon removal of the cofactor, PLP.
Mechanism of unfolding
Scheme l depicts the minimum model proposed to explain the GdnHCl-induced unfolding/refolding of sheep liver SHMT. Physical evidence for the presence of intermediates in the unfolding of SHMT was obtained using size exclusion chromatography ( figure 3a) . In case of the apoenzyme, the removal of PLP results in the dissociation of the tetramer as well as in the stabilization of one of the unfolding intermediates ( figure 3a) . Initially, the population of this intermediate (peak 3) increased with time at the expense of the dimer (peak 2). After 2-3 h of incubation another species appeared at 14.6 ml (peak 4) which was less compact than the first intermediate and more compact than the completely unfolded protein (figure 3a). The area under this peak increased with time at the expense of the first intermediate before reaching an equilibrium value. This species with a retention volume of 14.6 ml, might represent a second intermediate or could be an oligomeric product of the first intermediate. To check for the latter possibility, the effect of protein concentration on the accumulation of these intermediates was monitored. In the range of protein concentrations employed (62-5-187.5gg/ml), when the system reached equilibrium, the relative area under these peaks at all protein concentrations were comparable (data not shown). Higher concentrations of protein could not be used because of the problem of aggregation. The aggregated product which appeared above 250gg/ml eluted at 9.2 ml (data not shown). Whether the holoand the reduced holoenzymes also show similar intermediate(s) could not be clearly established because the unfolding intermediate eluted at the same elution volume as the folded tetramer and at 0.3-0.4 M GdnHCI, substantial amounts of native tetramer was still present. At higher GdnHCI, the intermediates are in fast exchange with the unfolded state resulting in a single peak which represents the weighted average of both the forms. But the results of ANS binding studies (figure 4) indicated that all the three forms of the enzyme unfold via a similar pathway. The maximum binding observed at 0.5 M GdnHC! suggests that the unfolding intermediate that accumulates at this concentration is less compact. A comparison of the urea/GdnHCl-induced unfolding of tetrameric SHMT is presented in table 2. The inactivation in the case of urea-induced denaturation was found to be due to the loss of PLP from the active site, whereas, in case of GdnHCI, the inactivation is due to competitive inhibition rather than the direct removal of PLP from the active site (figure 1). The predenaturation transition, defined as the event leading to dissociation and the formation of an intermediate dimer, which was very distinct during the urea-induced unfolding of holoSHMT is not evident in case of the GdnHCl-induced unfolding. The apoenzyme, in both the cases, dissociates to dimers prior to unfolding. In the case of GdnHCl, probably because of its stronger denaturing capacity than urea (Greene and Pace 1974) , the dimer is not a very stable intermediate. During both unfolding pathways, the dimer, probably directly without further dissociation, unfolded into an intermediate which showed increased affinity towards ANS. In the case of GdnHCl-induced unfolding, this intermediate is stabilized at low GdnHCI concentration (0.45M) and can be captured in size exclusion chromatography.
Another interesting comparison is the role of the cofactor during urea and GdnHCl-induced unfolding. In the case of urea-induced unfolding, the phosphopyridoxyl lysine residue present at the active site was able to afford considerable protection against unfolding. In the case of GdnHC1, the unfolding midpoints of all the three forms of the enzyme are comparable. Similarly, during the refolding pathway, in case of urea, the PLP was found to affect the dimer/tetramer equilibrium and shifted the equilibrium towards the formation of active tetramers. During the refolding of GdnHC1 denatured SHMT, in the absence of PLP, the protein elutes with an elution volume corresponding to that of the tetramer and can be converted to the active form upon addition of PLP. The results presented in this paper demonstrate that change of denaturant affects the equilibrium distribution of the unfolding intermediates.
